Skip To Main Content
Innovation. Previously on Muck Rack

Innovation. Previously

As seen in: Bio News
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Innovation.

Contact Innovation., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

NIH Innovation Zone 2024: Concerto Biosciences illuminates collaboration of microbes

|
By J.P. Carroll, Innovation. Previously, Spanish speaker
| Bio News
Microbial ecology and its potential applications are gaining prominence in biotechnology and healthcare. Cambridge-based Concerto Biosciences is helping drive advances in this area with its kChip technology, designed to unlock breakthroughs across diverse fields—from human health to environmental sustainability.
Open in Who Shared Issue with article?

BIO honors innovators with 2024 Leadership in Agri-Biotechnology Awards

|
By J.P. Carroll, Innovation. Previously, Spanish speaker
| Bio News
In recognition of significant advancements in biotechnology’s impact on our food supply, the Biotechnology Innovation Organization (BIO) recently recognized industry leaders who helped drive two pivotal achievements: the approval of the first genetically engineered animal for food and the development of the inaugural vaccine to protect honeybees.
Open in Who Shared Issue with article?

NIH Innovation Zone 2024: Immuto Scientific identifies new cancer targets

|
By J.P. Carroll, Innovation. Previously, Spanish speaker
| Bio News
Immuto Scientific is opening new frontiers in the fight against cancer by developing precision biotherapeutics that target highly cancer-specific surface protein conformations. Their ultimate goal is to make cancer curable. Immuto Scientific was one of the companies supported by the National Institutes of Health (NIH) SEED program that was chosen to present on the NIH Innovation Zone Stage at the 2024 BIO International Convention. Bio.News interviewed Immuto Scientific CEO Faraz A.
Open in Who Shared Issue with article?
See all 15 articles